SEOM clinical guidelines in metastatic breast cancer 2015

• J. Gavilá ^[1] ; S. Lopez-Tarruella ^[2] ; C. Saura ^[5] ; M. Muñoz ^[6] ; M. Oliveira ^[5] ; L. De la Cruz-Merino ^[3] ; S. Morales ^[7] ; I. Alvarez ^[8] ; J. A. Virizuela ^[3] ; M. Martin ^[4]
  1. [1] Instituto Valenciano de Oncologia

     Instituto Valenciano de Oncologia

     Valencia, España

     
  2. [2] Hospital General Universitario Gregorio Marañón

     Hospital General Universitario Gregorio Marañón

     Madrid, España

     
  3. [3] Hospital Universitario Virgen Macarena

     Hospital Universitario Virgen Macarena

     Sevilla, España

     
  4. [4] Instituto de Investigación Sanitaria Gregorio Marañón

     Instituto de Investigación Sanitaria Gregorio Marañón

     Madrid, España

     
  5. [5] Hospital Vall d’ Hebron
  6. [6] Hospital Clinic
  7. [7] Hospital Universitari Arnau de Villanova de Lleida
  8. [8] Hospital Donostia-Donostia Ospitalea

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 17, Nº. 12, 2015, págs. 946-955
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Dialnet Métricas: 1 Cita
• Resumen

  • Metastatic breast cancer is essentially an incurable disease. However, recent advances have resulted in a significant improvement of overall survival. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with meta- static breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.